Programmbereich Infektionen


Mission    Projekte    Drittmittel    Methoden    Publikationen    Mitarbeiter/innen


  • BMBF; DZIF TTU-TB 02.705 Infrastructure „Myco Drug and Trials“
  • BMBF; DZIF TTU-TB 02.806 Project „New Drugs and Regimen“
  • BMBF; DZIF TTU-TB 02.906 FlexFund „Optimization of mycobacterial thioredoxin reductase inhibitors, novel lead compounds against M. tuberculosis
  • BMBF; DZIF TTU-TI 07.003_Garrelts MD Project „Local activity of anti-TB therapeutics in highly stratified human-like lesions of a novel pre-clincial mouse model“
  • DFG; IRTG191: "Immunoregulation of Inflammation in Allergy and Infection“: Project B6 "ProThe impact of Tr1 cells in aged mice on susceptibility and vaccination efficacy in TB“
  • DFG; IRTG191: "Immunoregulation of Inflammation in Allergy and Infection“: MD Project "Spatial analysis of host and pathogen responses in highly structured tuberculous granulomas after laser capture microdissection“
  • DFG; GRK 1727: „Modulation von Autoimmunität“ : Projekt A3: "Cell type-specific effects of interleukin-17 in Epidermolysis bullous acquisita"